Influenza A virus vaccine H1N1 - Fluart Innovative Vaccines

Drug Profile

Influenza A virus vaccine H1N1 - Fluart Innovative Vaccines

Alternative Names: FLUVAL P H1N1; Influenza virus vaccine H1N1 monovalent - Fluart Innovative Vaccines

Latest Information Update: 15 Sep 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Omninvest
  • Developer Fluart Innovative Vaccines
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 01 Jan 2010 Launched for Influenza-A virus H1N1 subtype (prevention in children, adolescents and elderly) in Hungary (IM)
  • 06 Oct 2009 Registered for Influenza-A virus H1N1 subtype (in children aged 1-3 years) in Hungary (IM)
  • 06 Oct 2009 Registered for Influenza-A virus H1N1 subtype (prevention in children and adolescents aged 3-18 years) in Hungary (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top